CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Cullinan Therapeutics, Inc. (CGEM) on Thursday reported a loss of $47.6 million in its fourth quarter.
The Cambridge, Massachusetts-based company said it had a loss of 73 cents per share.
The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 75 cents per share.
For the year, the company reported that its loss widened to $167.4 million, or $2.78 per share.
Cullinan Therapeutics shares have fallen 31% since the beginning of the year. The stock has declined 53% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGEM at https://www.zacks.com/ap/CGEM
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
